8-K
filed May 8, 2023, 7:59 PM ET
ticker UTMD
CIK 0000706698
other material
confidence high
sentiment negative
materiality 0.15
UTMD shareholders reject 2023 incentive plan; directors with low support remain
UTAH MEDICAL PRODUCTS INC
- 2023 Employees’ and Directors’ Incentive Plan voted down: 1,168,480 for vs 1,590,668 against.
- Directors Hoyer (871,160 for, 1,926,073 withheld) and Beeson (1,277,218 for, 1,520,015 withheld) re-elected but board declined their resignations.
- Advisory say-on-pay passed with 2,719,953 for vs 72,499 against; shareholders prefer annual votes.
- Ratification of Haynie & Co. as auditor passed with 3,138,164 for.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
UTAH MEDICAL PRODUCTS INC shareholders approved Election of Directors at the 2023-05-05 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-05-05
Exact text from the filing
Elected Ernst G. Hoyer as a director of the Company: For 871,160 Withheld 1,926,073 Broker Non Votes 371,084 Elected James H. Beeson as a director of the Company: For 1,277,218 Withheld 1,520,015 Broker Non Votes 371,084
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
UTAH MEDICAL PRODUCTS INC shareholders approved Frequency of future advisory votes on executive compensation at the 2023-05-05 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-05-05
Exact text from the filing
Indicated a preference, the frequency of future advisory votes on the Company's executive compensation program: Every year: 2,412,492 Every two years: 17,765 Every three years: 167,728 Abstain: 199,248 Broker Non Votes: 371,084
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
UTAH MEDICAL PRODUCTS INC shareholders rejected 2023 Employees’ and Directors’ Incentive Plan at the 2023-05-05 meeting.
- Proposal
- equity plan
- Outcome
- failed
- Meeting
- 2023-05-05
Exact text from the filing
Did not approve the 2023 Employees’ and Directors’ Incentive Plan: For 1,168,480 Against 1,590,668 Abstentions 38,085
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
UTAH MEDICAL PRODUCTS INC shareholders approved Ratification of Haynie & Co. as independent public accounting firm at the 2023-05-05 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-05-05
Exact text from the filing
Ratified the selection of Haynie & Co. as the Company's independent public accounting firm for the year ended December 31, 2023: For 3,138,164 Against 27,552 Abstentions 2,601
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
UTAH MEDICAL PRODUCTS INC shareholders approved Advisory vote on executive compensation at the 2023-05-05 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-05-05
Exact text from the filing
Approved, on an advisory basis, the compensation paid to UTMD's named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: For 2,719,953 Against 72,499 Abstentions 4,781 Broker Non Votes 371,084
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.